Studies using cultured cells have shown that gamma interferon (IFN-'y) induces the expression of FcyRI (the type I Fc receptor for IgG) on human polymorphonuclear neutrophils (PMN) and greatly increases the number of these receptors on human monocytes. Administration of rIFN-y in vivo also causes enhanced Fc'yRI expression od these cell populations. Because streptococcal antigens are potent inducers of IFN-y in vitro, we postulated that IFN-'y would be produced endogenously in vivo in patients with streptococcal infections. Such production of IFN--y in vivo, even at low levels, might be expected to induce the expression of FcyRI on monocytes and neutrophils. To evaluate this possibility, we used monoclonal antibody 32 (mAb 32), which is specific for FcyRI, to quantitate the expression of this receptor on human peripheral blood cells. We measured the binding of mAb 32 to monocytes and PMNs isolated from healthy donors and from patients with group A
of resistance to infectious agents, including T. gondii (1), L.
monocytogenes (2) , L. donovani (3) , and R. conorii (4) . IFN-'y activates both murine and human mononuclear phagocytes, increasing oxidative metabolism (5, 6) , antimicrobial activity (7, 8) , and receptors for the Fc portion ofhuman immunoglobulin G (FcyR) (9, 10) . Three FcyR (FcyRI, II, and III) have been identified in association with human myeloid cells (reviewed by Unkeless et al., reference 1 1) and are recognized respectively by monoclonal antibodies 32 (12) , IV.3 (13) , and 3G8 (14) . FcyRI has high affinity for human IgG 1 , is constitutively expressed on monocytes, and is induced to much higher expression in response to IFN--y (9) . Moreover, we recently used mAb 32 to show that while polymorphonuclear neutrophils (PMNs) have < 3,000 FcyRI per cell, culture for 18 h with 40 U/ml of recombinant IFN-,y results in the expression of 8,000-20,000 Fc'yRI per PMN (15) . Consistent with this effect of IFN-y on monocytes and PMNs in vitro, it has been demonstrated that parenteral administration of rIFN-'y to patients causes increased expression of FcyRI on circulating monocytes (16) and PMNs (Guyre P. M., and M. B. Gamick, unpublished observations) and also increases the capacity of monocytes to produce reactive oxygen intermediates (6) .
Because streptococcal antigens are potent inducers of IFN-'y production (17, 18) Cell preparation. 20 ml of venous blood was collected into 10-ml vacutainer tubes containing sodium heparin (Becton Dickinson, Rutherford, NJ). Mononuclear cells were separated from PMN on Ficoll/Hypaque according to Boyum (20) . PMNs were separated from RBC by dextran sedimentation (21). Nucleated cells were washed with RPMI 1640 and contaminating RBC were removed by osmotic lysis; osmolarity was restored with hypertonic PBS. Cells were washed again with RPMI 1640 and resuspended in RPMI/Hepes/0.2% BSA. PMNs and mononuclear cells were recombined in a 1:4 ratio because we found this proportion to be optimal for analysis by flow cytometry.
Fc,yR assay. Fc-yR were examined by indirect immunofluoresence staining using purified mAb specific to each of the three known FcyR (15) . These are mAb 32 (Fc-yRI; reference 12), mAb IV.3 (FcyRII; reference 13) IFN--y assays. Plasma was obtained from the same heparinized tubes from which the leukocytes were isolated, made platelet-poor by centrifugation at 450 g for 30 min, and frozen at -70°C for up to I mo before assay. Five plasma samples were also tested within 2 h of isolation. Samples were tested using a commercially available radioimmunoassay (Centecor, Inc., Malvern, PA) which is specific for bioactive IFN-,y, and by a bioassay which is based on increased expression of 
Results
Streptococcal infection increases FcyRI. Fig. 1 A summarizes the major finding of this study, that PMNs isolated on the day of initial evaluation from eight of nine patients with GABHS pharyngitis had significantly elevated levels of surface FcYRI. PMNs from 12 healthy normal donors had 700±600 (mean±SD) mAb 32 binding sites. 11 patients with pharyngitis and negative throat culture for GABHS had a mean of 2,100±1,600 sites on their PMNs, a value significantly higher than for controls (P < 0.05). In contrast, PMNs from nine patients with documented GABHS pharyngitis had 11,600±7,500 mAb 32 binding sites on their surface. This was significantly higher than both the healthy donor group (P < 0.0005) and the GABHS-negative throat culture group (P < 0.0005). The GABHS-negative group included three patients (Nos. 2, 4, and 6, of Fig. 1 (Fig. 1 A, right) and on monocytes ( Fig. 1 B, (Fig. 3). Fig. 3 4 shows that the levels of binding of these mAbs were equivalent for all three groups. Thus, in contrast to FcyRI, the expression of FcyRII and FcyRIII was unaffected by GABHS infection. (Fc-yRII) and mAb 3G8 (Fc-yRIII) sites per cell for the healthy control group (n = 12), the culture negative group (n = 11), and the GABHS pharyngitis positive group (n = 9).
Gram negative urinary tract infection does not alter FcyRI expression. 10 patients with documented urinary tract infections were found to not have increased binding of mAb 32 to monocytes or PMN (Table I) . Three patients with apparently uncomplicated pyelonephritis had a mean of 33,500 binding sites on their monocytes and 3,400 sites on their PMN, levels similar to pharyngitis patients who were GABHS negative. Two additional pyelonephritis patients had elevated FcyRI on their PMNs. These patients, in addition to pyelonephritis, also had either E. coli septicemia or pneumonia of unknown etiology (Table I) .
IFN-,y is undetectable in patient's plasma. IFN-'y is a potent inducer of Fc-yRI expression by both monocytes and
PMNs (9, 10, 15) and its production is induced by streptococcal antigens (17, 18) . We therefore examined plasma samples, obtained at the same time that elevated numbers of FcyRI were detected on leukocytes, for the presence of IFN--y. Seven plasma samples were obtained and frozen at -70°C, then tested using an IFN-y-specific RIA (Centocor, Inc., Malvern, PA). All samples had undetectable IFN-'y (< 1 U/ml).
We next obtained blood from three donors as soon as possible after their throat cultures were found to contain GABHS, examined the cells for FchyRI expression, and tested the plasma within 2 h of isolation for IFN-,y. This test for IFN--y included both the RIA and a bioassay (22) which detects increased expression of FcyRI on the U-937 cell line. Fig. 5 shows the result for plasma samples obtained from donors K.B. and A.L.; leukocyte Fc'yRI levels for the same blood samples are shown to be elevated in Fig. 3 . Neither plasma from the normal donor (CON) nor from the GABHS patients (K.B. and A.L.) caused a significant increase in mAb 32 binding to (Fig. 2) . Thus, streptococcal infection results in systemic activation of FcyRI expression in all circulating monocytes and PMNs. The second possibility is plausible since the serum half-life of rIFN-y has been estimated to be between 0.5 and 3 h (24-26). Moreover, Chatenoud et al. (27) In summary, we find increased FcyRI expression on the entire circulating pool of both PMNs and monocytes isolated from patients with GABHS pharyngitis. This increase might result from a transiently high level of production of IFN-y and G-CSF, but probably reflects the interactive effects of several as yet to be identified hormones and cytokines. Further studies will be required to determine the types of infectious illnesses that are associated with increased expression of Fc-yRI.
